SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/16/19 Cannex Capital Holdings Inc. 40FR12G 138:29M Newsfile Corp/FA |
Document/Exhibit Description Pages Size 1: 40FR12G Registration of Securities of a Canadian Issuer HTML 112K 2: EX-99.1 Miscellaneous Exhibit -- exhibit99-1 HTML 53K 11: EX-99.10 Miscellaneous Exhibit -- exhibit99-10 HTML 30K 101: EX-99.100 Miscellaneous Exhibit -- exhibit99-100 HTML 49K 102: EX-99.101 Miscellaneous Exhibit -- exhibit99-101 HTML 872K 103: EX-99.102 Miscellaneous Exhibit -- exhibit99-102 HTML 78K 104: EX-99.103 Miscellaneous Exhibit -- exhibit99-103 HTML 70K 105: EX-99.104 Miscellaneous Exhibit -- exhibit99-104 HTML 35K 106: EX-99.105 Miscellaneous Exhibit -- exhibit99-105 HTML 2.88M 107: EX-99.106 Miscellaneous Exhibit -- exhibit99-106 HTML 34K 108: EX-99.107 Miscellaneous Exhibit -- exhibit99-107 HTML 33K 109: EX-99.108 Miscellaneous Exhibit -- exhibit99-108 HTML 39K 110: EX-99.109 Miscellaneous Exhibit -- exhibit99-109 HTML 290K 12: EX-99.11 Miscellaneous Exhibit -- exhibit99-11 HTML 156K 111: EX-99.110 Miscellaneous Exhibit -- exhibit99-110 HTML 133K 112: EX-99.111 Miscellaneous Exhibit -- exhibit99-111 HTML 33K 113: EX-99.112 Miscellaneous Exhibit -- exhibit99-112 HTML 33K 114: EX-99.113 Miscellaneous Exhibit -- exhibit99-113 HTML 42K 115: EX-99.114 Miscellaneous Exhibit -- exhibit99-114 HTML 32K 116: EX-99.115 Miscellaneous Exhibit -- exhibit99-115 HTML 39K 117: EX-99.116 Miscellaneous Exhibit -- exhibit99-116 HTML 34K 118: EX-99.117 Miscellaneous Exhibit -- exhibit99-117 HTML 37K 119: EX-99.118 Miscellaneous Exhibit -- exhibit99-118 HTML 455K 120: EX-99.119 Miscellaneous Exhibit -- exhibit99-119 HTML 133K 13: EX-99.12 Miscellaneous Exhibit -- exhibit99-12 HTML 30K 121: EX-99.120 Miscellaneous Exhibit -- exhibit99-120 HTML 33K 122: EX-99.121 Miscellaneous Exhibit -- exhibit99-121 HTML 33K 123: EX-99.122 Miscellaneous Exhibit -- exhibit99-122 HTML 41K 124: EX-99.123 Miscellaneous Exhibit -- exhibit99-123 HTML 36K 125: EX-99.124 Miscellaneous Exhibit -- exhibit99-124 HTML 491K 126: EX-99.125 Miscellaneous Exhibit -- exhibit99-125 HTML 140K 127: EX-99.126 Miscellaneous Exhibit -- exhibit99-126 HTML 33K 128: EX-99.127 Miscellaneous Exhibit -- exhibit99-127 HTML 33K 129: EX-99.128 Miscellaneous Exhibit -- exhibit99-128 HTML 30K 130: EX-99.129 Miscellaneous Exhibit -- exhibit99-129 HTML 492K 14: EX-99.13 Miscellaneous Exhibit -- exhibit99-13 HTML 32K 131: EX-99.130 Miscellaneous Exhibit -- exhibit99-130 HTML 143K 132: EX-99.131 Miscellaneous Exhibit -- exhibit99-131 HTML 32K 133: EX-99.132 Miscellaneous Exhibit -- exhibit99-132 HTML 32K 134: EX-99.133 Miscellaneous Exhibit -- exhibit99-133 HTML 30K 135: EX-99.134 Miscellaneous Exhibit -- exhibit99-134 HTML 69K 136: EX-99.135 Miscellaneous Exhibit -- exhibit99-135 HTML 31K 137: EX-99.136 Miscellaneous Exhibit -- exhibit99-136 HTML 29K 138: EX-99.137 Miscellaneous Exhibit -- exhibit99-137 HTML 30K 15: EX-99.14 Miscellaneous Exhibit -- exhibit99-14 HTML 32K 16: EX-99.15 Miscellaneous Exhibit -- exhibit99-15 HTML 32K 17: EX-99.16 Miscellaneous Exhibit -- exhibit99-16 HTML 33K 18: EX-99.17 Miscellaneous Exhibit -- exhibit99-17 HTML 34K 19: EX-99.18 Miscellaneous Exhibit -- exhibit99-18 HTML 42K 20: EX-99.19 Miscellaneous Exhibit -- exhibit99-19 HTML 33K 3: EX-99.2 Miscellaneous Exhibit -- exhibit99-2 HTML 31K 21: EX-99.20 Miscellaneous Exhibit -- exhibit99-20 HTML 45K 22: EX-99.21 Miscellaneous Exhibit -- exhibit99-21 HTML 145K 23: EX-99.22 Miscellaneous Exhibit -- exhibit99-22 HTML 77K 24: EX-99.23 Miscellaneous Exhibit -- exhibit99-23 HTML 32K 25: EX-99.24 Miscellaneous Exhibit -- exhibit99-24 HTML 32K 26: EX-99.25 Miscellaneous Exhibit -- exhibit99-25 HTML 35K 27: EX-99.26 Miscellaneous Exhibit -- exhibit99-26 HTML 28K 28: EX-99.27 Miscellaneous Exhibit -- exhibit99-27 HTML 38K 29: EX-99.28 Miscellaneous Exhibit -- exhibit99-28 HTML 34K 30: EX-99.29 Miscellaneous Exhibit -- exhibit99-29 HTML 782K 4: EX-99.3 Miscellaneous Exhibit -- exhibit99-3 HTML 28K 31: EX-99.30 Miscellaneous Exhibit -- exhibit99-30 HTML 30K 32: EX-99.31 Miscellaneous Exhibit -- exhibit99-31 HTML 49K 33: EX-99.32 Miscellaneous Exhibit -- exhibit99-32 HTML 31K 34: EX-99.33 Miscellaneous Exhibit -- exhibit99-33 HTML 51K 35: EX-99.34 Miscellaneous Exhibit -- exhibit99-34 HTML 35K 36: EX-99.35 Miscellaneous Exhibit -- exhibit99-35 HTML 36K 37: EX-99.36 Miscellaneous Exhibit -- exhibit99-36 HTML 42K 38: EX-99.37 Miscellaneous Exhibit -- exhibit99-37 HTML 36K 39: EX-99.38 Miscellaneous Exhibit -- exhibit99-38 HTML 38K 40: EX-99.39 Miscellaneous Exhibit -- exhibit99-39 HTML 35K 5: EX-99.4 Miscellaneous Exhibit -- exhibit99-4 HTML 30K 41: EX-99.40 Miscellaneous Exhibit -- exhibit99-40 HTML 35K 42: EX-99.41 Miscellaneous Exhibit -- exhibit99-41 HTML 35K 43: EX-99.42 Miscellaneous Exhibit -- exhibit99-42 HTML 35K 44: EX-99.43 Miscellaneous Exhibit -- exhibit99-43 HTML 36K 45: EX-99.44 Miscellaneous Exhibit -- exhibit99-44 HTML 31K 46: EX-99.45 Miscellaneous Exhibit -- exhibit99-45 HTML 28K 47: EX-99.46 Miscellaneous Exhibit -- exhibit99-46 HTML 454K 48: EX-99.47 Miscellaneous Exhibit -- exhibit99-47 HTML 29K 49: EX-99.48 Miscellaneous Exhibit -- exhibit99-48 HTML 114K 50: EX-99.49 Miscellaneous Exhibit -- exhibit99-49 HTML 33K 6: EX-99.5 Miscellaneous Exhibit -- exhibit99-5 HTML 1.56M 51: EX-99.50 Miscellaneous Exhibit -- exhibit99-50 HTML 33K 52: EX-99.51 Miscellaneous Exhibit -- exhibit99-51 HTML 49K 53: EX-99.52 Miscellaneous Exhibit -- exhibit99-52 HTML 31K 54: EX-99.53 Miscellaneous Exhibit -- exhibit99-53 HTML 44K 55: EX-99.54 Miscellaneous Exhibit -- exhibit99-54 HTML 31K 56: EX-99.55 Miscellaneous Exhibit -- exhibit99-55 HTML 297K 57: EX-99.56 Miscellaneous Exhibit -- exhibit99-56 HTML 101K 58: EX-99.57 Miscellaneous Exhibit -- exhibit99-57 HTML 33K 59: EX-99.58 Miscellaneous Exhibit -- exhibit99-58 HTML 33K 60: EX-99.59 Miscellaneous Exhibit -- exhibit99-59 HTML 37K 7: EX-99.6 Miscellaneous Exhibit -- exhibit99-6 HTML 499K 61: EX-99.60 Miscellaneous Exhibit -- exhibit99-60 HTML 34K 62: EX-99.61 Miscellaneous Exhibit -- exhibit99-61 HTML 31K 63: EX-99.62 Miscellaneous Exhibit -- exhibit99-62 HTML 33K 64: EX-99.63 Miscellaneous Exhibit -- exhibit99-63 HTML 35K 65: EX-99.64 Miscellaneous Exhibit -- exhibit99-64 HTML 33K 66: EX-99.65 Miscellaneous Exhibit -- exhibit99-65 HTML 36K 67: EX-99.66 Miscellaneous Exhibit -- exhibit99-66 HTML 37K 68: EX-99.67 Miscellaneous Exhibit -- exhibit99-67 HTML 37K 69: EX-99.68 Miscellaneous Exhibit -- exhibit99-68 HTML 31K 70: EX-99.69 Miscellaneous Exhibit -- exhibit99-69 HTML 37K 8: EX-99.7 Miscellaneous Exhibit -- exhibit99-7 HTML 155K 71: EX-99.70 Miscellaneous Exhibit -- exhibit99-70 HTML 33K 72: EX-99.71 Miscellaneous Exhibit -- exhibit99-71 HTML 30K 73: EX-99.72 Miscellaneous Exhibit -- exhibit99-72 HTML 32K 74: EX-99.73 Miscellaneous Exhibit -- exhibit99-73 HTML 177K 75: EX-99.74 Miscellaneous Exhibit -- exhibit99-74 HTML 37K 76: EX-99.75 Miscellaneous Exhibit -- exhibit99-75 HTML 35K 77: EX-99.76 Miscellaneous Exhibit -- exhibit99-76 HTML 159K 78: EX-99.77 Miscellaneous Exhibit -- exhibit99-77 HTML 160K 79: EX-99.78 Miscellaneous Exhibit -- exhibit99-78 HTML 42K 80: EX-99.79 Miscellaneous Exhibit -- exhibit99-79 HTML 35K 9: EX-99.8 Miscellaneous Exhibit -- exhibit99-8 HTML 75K 81: EX-99.80 Miscellaneous Exhibit -- exhibit99-80 HTML 35K 82: EX-99.81 Miscellaneous Exhibit -- exhibit99-81 HTML 588K 83: EX-99.82 Miscellaneous Exhibit -- exhibit99-82 HTML 46K 84: EX-99.83 Miscellaneous Exhibit -- exhibit99-83 HTML 50K 85: EX-99.84 Miscellaneous Exhibit -- exhibit99-84 HTML 47K 86: EX-99.85 Miscellaneous Exhibit -- exhibit99-85 HTML 35K 87: EX-99.86 Miscellaneous Exhibit -- exhibit99-86 HTML 355K 88: EX-99.87 Miscellaneous Exhibit -- exhibit99-87 HTML 130K 89: EX-99.88 Miscellaneous Exhibit -- exhibit99-88 HTML 33K 90: EX-99.89 Miscellaneous Exhibit -- exhibit99-89 HTML 33K 10: EX-99.9 Miscellaneous Exhibit -- exhibit99-9 HTML 32K 91: EX-99.90 Miscellaneous Exhibit -- exhibit99-90 HTML 37K 92: EX-99.91 Miscellaneous Exhibit -- exhibit99-91 HTML 35K 93: EX-99.92 Miscellaneous Exhibit -- exhibit99-92 HTML 39K 94: EX-99.93 Miscellaneous Exhibit -- exhibit99-93 HTML 35K 95: EX-99.94 Miscellaneous Exhibit -- exhibit99-94 HTML 59K 96: EX-99.95 Miscellaneous Exhibit -- exhibit99-95 HTML 35K 97: EX-99.96 Miscellaneous Exhibit -- exhibit99-96 HTML 42K 98: EX-99.97 Miscellaneous Exhibit -- exhibit99-97 HTML 31K 99: EX-99.98 Miscellaneous Exhibit -- exhibit99-98 HTML 39K 100: EX-99.99 Miscellaneous Exhibit -- exhibit99-99 HTML 48K
Cannex Capital Holdings Inc.: Exhibit 99.37 - Filed by newsfilecorp.com |
CANNEX CLARIFIES JETTY ACQUISITION TERMS
VANCOUVER, BC, April 9, 2018 - Cannex Capital Holdings Inc. (CSE: CNNX) (“Cannex” or the “Company”) provides the following clarification to the news release disseminated earlier today regarding the acquisition of Ametrine Wellness Inc. dba Jetty Extracts (“Jetty”) (the “Transaction”), in particular certain escrow conditions to which the consideration shares being paid to certain of the Jetty shareholders will be subject under the Definitive Agreement. All capitalized terms in this clarifying news release not identified have the same meaning as the earlier news release announcing the Transaction.
The Company wishes to clarify that approximately 80% of all securities issued as consideration in the Transaction will be subject to escrow provisions whereby the insiders of Jetty will receive 10% of their share consideration upon closing of the Transaction and the balance of the share consideration over a period of three years, with releases of 15% of the total consideration each six months. In addition to the three-year limited-release lock-up, all shares issued in the Transaction will be subject to a statutory Canadian hold-period of four months plus one day from the date of issuance.
Anthony Dutton, Cannex CEO stated, “The three-year limited release escrow for Jetty insiders will put Jetty on the same footing as the shareholders of BrightLeaf Development LLC (“BLD”) in Cannex’ initial acquisition, and demonstrates both Jetty’s and BLD’s commitment to Cannex’s strategy of growth through partnership”.
The Transaction is subject to a number of conditions, including but not limited to, final due diligence by the respective parties, execution of a Definitive Agreement, receipt of applicable corporate approvals, and other regulatory and/or governmental approval. There can be no assurance that the Transaction will be completed as proposed or at all.
About Cannex Capital Holdings Inc.
Cannex, through its wholly-owned subsidiaries, provides a wide range of services including real estate, management, financial, branding and IP to licensed cannabis business operators domestically and internationally. Cannex is focused on premium indoor cultivation, extraction, manufacturing and branding of edible and derivative products as well as retail operations. Cannex is undertaking expansion initiatives to support the acquisition and development of additional assets in legal medical and recreational cannabis markets. Based in Vancouver, BC, Cannex is managed by a team of experienced industry and capital markets experts who are committed to aggressive, cost-effective growth. Cannex currently owns BrightLeaf Development LLC which holds real estate assets, property leases, brands and intellectual property, and material supply agreements with Superior Gardens LLC (d/b/a Northwest Cannabis Solutions), Washington State’s and the Pacific Northwest’s largest full-line cannabis producer/processor, as well as 7Point Holdings LLC, another Washington State licensed cannabis producer/processor.
About Jetty Extracts
Founded in 2013, Jetty Extracts is one of the true originals in the California Extracts market. Jetty began its operations in San Diego, California with a focus on craft and innovation while applying a strict adherence to compliance, fiscal responsibility, environmental concerns and community commitment (with a little time for some surfing in between). Today, Jetty’s 60-plus employees work in San Diego and the company’s 12,000 sq ft Oakland, California headquarters and production facility, utilizing the latest technology to create its additive- and pesticide-free oils including its whole-plant terpene Gold cartridges, Dablicator™ and other products. Jetty maintains a partnership with and 50% ownership in, award-winning toffee edible brand, MindTricks™ and operates The Shelter Project, a standalone non-profit that provides free cannabis to cancer patients www.jettyextracts.com.
Cannex Capital Holdings Inc.
Anthny Dutton, CEO
(604) 649-7787
Email:
adutton@cannexcapital.com
Website:
www.cannexcapital.com
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The information in this news release pertaining to Jetty was provided by Jetty. Although Cannex does not have any knowledge that would indicate that such information is untrue or incomplete, neither Cannex nor any of its directors or officers assumes any responsibility for the accuracy or completeness of such information.
Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Cannex’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements related to the proposed acquisition of Jetty, the proposed interim financing of Jetty, the size of the cannabis market in California, Cannex’s expansion plans, and other statements of fact.
Although Cannex has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Cannex disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Cannex does not assume any liability for disclosure relating to any other company mentioned herein.
2
This news release was prepared by management of Cannex, which takes full responsibility for its contents. The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
3
This ‘40FR12G’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 7/16/19 | None on these Dates | ||
4/9/18 | ||||
List all Filings |